Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Sees Large Decrease in Short Interest

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) was the recipient of a large drop in short interest in November. As of November 15th, there was short interest totalling 1,110,000 shares, a drop of 7.5% from the October 31st total of 1,200,000 shares. Based on an average daily trading volume, of 316,700 shares, the days-to-cover ratio is currently 3.5 days. Currently, 2.0% of the shares of the stock are sold short.

Aveanna Healthcare Stock Up 0.7 %

NASDAQ AVAH opened at $5.85 on Tuesday. The firm has a market capitalization of $1.13 billion, a PE ratio of -17.15 and a beta of 2.13. The stock’s 50 day moving average is $5.23 and its 200 day moving average is $4.30. Aveanna Healthcare has a twelve month low of $2.00 and a twelve month high of $6.19.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The business had revenue of $509.02 million during the quarter, compared to analysts’ expectations of $495.80 million. During the same period in the prior year, the company earned ($0.05) earnings per share. On average, research analysts anticipate that Aveanna Healthcare will post -0.09 earnings per share for the current year.

Hedge Funds Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Jacobs Levy Equity Management Inc. boosted its position in shares of Aveanna Healthcare by 297.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 355,340 shares of the company’s stock worth $1,848,000 after purchasing an additional 265,969 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Aveanna Healthcare during the third quarter valued at $817,000. Renaissance Technologies LLC boosted its holdings in Aveanna Healthcare by 155.8% in the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after acquiring an additional 96,600 shares in the last quarter. Jane Street Group LLC grew its stake in shares of Aveanna Healthcare by 127.4% in the third quarter. Jane Street Group LLC now owns 118,803 shares of the company’s stock worth $618,000 after acquiring an additional 66,561 shares during the last quarter. Finally, Geode Capital Management LLC increased its holdings in shares of Aveanna Healthcare by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company’s stock valued at $7,287,000 after acquiring an additional 63,190 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on AVAH. Deutsche Bank Aktiengesellschaft increased their target price on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a research note on Friday, August 9th. UBS Group raised their price objective on Aveanna Healthcare from $1.70 to $2.80 and gave the company a “sell” rating in a report on Friday, August 9th. Finally, Royal Bank of Canada increased their price target on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the company a “sector perform” rating in a research report on Friday, August 9th.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.